Yusuf Tutar

24PUBLICATIONS
55CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 27, 2026
Trifluoromethyl-Benzimidazole-Hydrazone Derivatives as Promising Selective Anticancer Agents: Synthesis, Cytotoxicity, and Molecular Docking Insights.

|Aug 24, 2026
Molecular Alterations Associated with Reduced 5-FU Sensitivity in mtDNA-Depleted HGC-27 Cells.

|Jul 28, 2026
Molecular Mechanisms and Molecular Subtype-Specific Responses to Paclitaxel in Breast Cancer Cells.

|Jul 03, 2026
Evaluation of the Anticancer Potential of Nitro-Benzimidazole Derivatives in Breast Cancer.

|Jun 25, 2026
Prognostic and Clinical Significance of Circulating Cystatin C Levels in Cancer Patients: A Meta-Analysis.

|May 04, 2026
The Effect of Cannabidiol on Cancer-Pathway Genes in Doxorubicin-Sensitive and Resistant Breast Cancer Cells.

Pageof 4

Frequent Collaborators

12 joint publications

Ayşe Büşranur Çelik

5 joint publications

Kübra Açıkalın Coşkun

5 joint publications

Emir Çapkınoğlu

4 joint publications

Kezban Uçar Çifçi